IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Immunocellular Therapeutics

Q4 2016 vs Q1 2017

Comparing institutional holders between quarters

Quarters

Q1 2017Q4 2016Q3 2016Q2 2016Q1 2016
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile
D'Orazio & Associates, Inc.
UNCHANGED
Shares75 from 75
Change0 (0%)
Value$0 ($0)
Filed 2017-05-16
Status
D'Orazio & Associates, Inc.
UNCHANGED757500%$0$0$02017-05-16
Showing 1 of 1 institutions